Evidence map›Paper›PMID 26387537›Full record

ArticleOncogene2016

MOF maintains transcriptional programs regulating cellular stress response.

B N Sheikh, W Bechtel-Walz, J Lucci, O Karpiuk, I Hild, B Hartleben, J Vornweg, M Helmstädter, A H Sahyoun, V Bhardwaj and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. HBO1, a MYSTerious KAT and its links to cancer.Biochimica et biophysica acta. Gene regulatory mechanisms · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

B N SheikhDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
W Bechtel-WalzRenal Division, University Medical Center, Freiburg, Germany.
J LucciDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
O KarpiukDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
I HildRenal Division, University Medical Center, Freiburg, Germany.
B HartlebenRenal Division, University Medical Center, Freiburg, Germany.
J VornwegRenal Division, University Medical Center, Freiburg, Germany.
M HelmstädterRenal Division, University Medical Center, Freiburg, Germany.
A H SahyounDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
V BhardwajDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
T StehleDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
S DiehlDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
O KretzRenal Division, University Medical Center, Freiburg, Germany.
A K VossDevelopment and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
T ThomasDevelopment and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
T MankeDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
T B HuberRenal Division, University Medical Center, Freiburg, Germany.
A AkhtarDepartment of Chromatin Regulation, Max Planck Institute of Immunobiology and Epigenetics, Freiburg im Breisgau, Germany.
Max Planck Institute of Immunobiology and Epigenetics · DEUniversity Medical Center Freiburg · DEUniversity of Freiburg · DEUniversity of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

European Research Council 616891
6 · The paper itself

Abstract

MOF (MYST1, KAT8) is the major H4K16 lysine acetyltransferase (KAT) in Drosophila and mammals and is essential for embryonic development. However, little is known regarding the role of MOF in specific cell lineages. Here we analyze the differential role of MOF in proliferating and terminally differentiated tissues at steady state and under stress conditions. In proliferating cells, MOF directly binds and maintains the expression of genes required for cell cycle progression. In contrast, MOF is dispensable for terminally differentiated, postmitotic glomerular podocytes under physiological conditions. However, in response to injury, MOF is absolutely critical for podocyte maintenance in vivo. Consistently, we detect defective nuclear, endoplasmic reticulum and Golgi structures, as well as presence of multivesicular bodies in vivo in podocytes lacking Mof following injury. Undertaking genome-wide expression analysis of podocytes, we uncover several MOF-regulated pathways required for stress response. We find that MOF, along with the members of the non-specific lethal but not the male-specific lethal complex, directly binds to genes encoding the lysosome, endocytosis and vacuole pathways, which are known regulators of podocyte maintenance. Thus, our work identifies MOF as a key regulator of cellular stress response in glomerular podocytes.

Indexed as

AnimalsCell Cycle CheckpointsHeat-Shock ProteinsHistone AcetyltransferasesHumansMiceMice, Inbred C57BLMice, TransgenicNuclear ProteinsPodocytesScavenger Receptors, Class AStress, PhysiologicalTranscription, GeneticHeat-Shock ProteinsHistone AcetyltransferasesKAT8 protein, humanKat8 protein, mouseNuclear ProteinsSCARA3 protein, humanScavenger Receptors, Class A

Identifiers

PMID26387537
PMCPMC4893634
OpenAlexW2227717222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.